PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L2549-LogicBioPatent and Technology License Agreement • October 9th, 2018 • LogicBio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Texas
Contract Type FiledOctober 9th, 2018 Company Industry JurisdictionThis Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 201 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and LogicBio Therapeutics, Inc., a Delaware corporation, with its principal place of business at 700 Main Street, Cambridge, MA 02139 (“Licensee”) (collectively, “Parties”, or singly, “Party”).
PATENT & TECHNOLOGY LICENSE AGREEMENT AGT. NO. L2549-LogicBioPatent and Technology License Agreement • August 13th, 2018 • LogicBio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Texas
Contract Type FiledAugust 13th, 2018 Company Industry JurisdictionThis Patent and Technology License Agreement (“Agreement”) is between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas whose address is 201 West 7th Street, Austin, Texas 78701 on behalf of The University of Texas Southwestern Medical Center (“UT Southwestern”), a component institution of System, whose address is 5323 Harry Hines Boulevard, Dallas, Texas 75390-9094 (“Licensor”) and LogicBio Therapeutics, Inc., a Delaware corporation, with its principal place of business at 700 Main Street, Cambridge, MA 02139 (“Licensee”) (collectively, “Parties”, or singly, “Party”).